Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: A retrospective cohort study of 7977 patients at Mayo Clinic

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 1, 2008, Pages 10-18

  From, Aaron M ^a   Bartholmai, Brian J ^a   Williams, Amy W ^a   Cha, Stephen S ^a   Pflueger, Axel ^a   McDonald, Furman S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CONTRAST MEDIUM; CREATININE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; DRUG EFFECT; DRUG POTENTIATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; CONTRAST MEDIA; CREATININE; DRUG SYNERGISM; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SODIUM BICARBONATE;

EID: 38749108528     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03100707     Document Type: Article

References (34)

1. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW: Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 103: 368-375, 1997
2. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT: Hospital-acquired renal insufficiency: A prospective study. Am J Med 74: 243-248, 1983
3. Iakovou I, Dangas G, Mehran R, Lansky AJ, Ashby DT, Fahy M, Mintz GS, Kent KM, Pichard AD, Satler LF, Stone GW, Leon MB: Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol 15: 18-22, 2003
4. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR Jr: Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105: 2259-2264, 2002
5. Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality. A cohort analysis. JAMA 275: 1489-1494, 1996
6. Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, De Metrio M, Galli S, Fabbiocchi F, Montorsi P, Veglia F, Bartorelli AL: N-Acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 354: 2773-2782, 2006
7. Kandzari DE, Rebeiz AG, Wang A, Sketch MH Jr: Contrast nephropathy: An evidence-based approach to prevention. Am J Cardiovasc Drugs 3: 395-405, 2003
8. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW: Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 89: 356-358, 2002
9. Kay J, Chow WH, Chan TM, Lo SK, Kwok OH, Yip A, Fan K, Lee CH, Lam WF: Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: A randomized controlled trial. JAMA; 289: 553-558, 2003
10. Briguori C, Manganelli F, Scarpato P, Elia PP, Golia B, Riviezzo G, Lepore S, Librera M, Villari B, Colombo A, Ricciardelli B: Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol 40: 298-303, 2002
11. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W: Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343: 180-184, 2000
12. Shyu KG, Cheng JJ, Kuan P: Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 40: 1383-1388, 2002
13. Merten GJ, Burgess WP, Gray LV, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA 3rd, Rittase RA, Norton HJ, Kennedy TP: Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial. JAMA 291: 2328-2334, 2004
14. Chertow GM: Prevention of radiocontrast nephropathy: Back to basics. JAMA 291: 2376-2377, 2004
15. Barrett BJ, Parfrey PS: Clinical practice: Preventing nephropathy induced by contrast medium. N Engl J Med 354: 379-386, 2006
16. Bagshaw SM, McAlister FA, Manns BJ, Ghali WA: Acetylcysteine in the prevention of contrast-induced nephropathy: A case study in the pitfalls of the evolution of evidence. Arch Intern Med 166: 161-166, 2006
17. Allaqaband S, Tumuluri R, Malik AM, Gupta A, Volkert P, Shalev Y, Bajwa TK: Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc Interv 57: 279-283, 2002
18. Boccalandro F, Arnhad M, Smalling RW, Sdringola S: Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast. Catheter Cardiovasc Interv 58: 336-341, 2003
19. Durham JD, Caputo C, Dokko J, Zaharakis T, Pahlavan M, Keltz J, Dutka P, Marzo K, Maesaka JK, Fishbane S: A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 62: 2202-2207, 2002
20. Pannu N, Wiebe N, Tonelli M; Alberta Kidney Disease Network: Prophylaxis strategies for contrast-induced nephropathy. JAMA 295: 2765-2779, 2006
21. Maeder M, Klein M, Fehr T, Rickli H: Contrast nephropathy: Review focusing on prevention. J Am Coll Cardiol 44: 1763-1771, 2004
22. Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, Jacobsen SJ: Trends in heart failure incidence and survival in a community-based population. JAMA 292: 344-350, 2004
23. Birck R, Krzossok S, Markowetz F, Schnulle P, van der Woude FJ, Braun C: Acetylcysteine for prevention of contrast nephropathy: Meta-analysis. Lancet 362: 598-603, 2003
24. Gami AS, Garovic VD: Contrast nephropathy after coronary angiography. Mayo Clin Proc 79: 211-219, 2004
25. Rubin DB: Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127: 757-763, 1997
26. Hoffman RM, Barry MJ, Stanford JL, Hamilton AS, Hunt WC, Collins MM: Health outcomes in older men with localized prostate cancer: Results from the Prostate Cancer Outcomes Study. Am J Med 119: 418-425, 2006
27. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
28. Poggio ED, Wang X, Weinstein DM, Issa N, Dennis VW, Braun WE, Hall PM: Assessing glomerular filtration rate by estimation equations in kidney transplant recipients. Am J Transplant 6: 100-108, 2006
29. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39[Suppl 1]: Sl-S266, 2002
30. Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M, Lacchetti C, Leung TW, Darling E, Bryant DM, Bucher HC, Schünemann HJ, Meade MO, Cook DJ, Erwin PJ, Sood A, Sood R, Lo B, Thompson CA, Zhou Q, Mills E, Guyatt GH: Randomized trials stopped early for benefit. JAMA 294: 2203-2209, 2005
31. Recio-Mayoral A, Chaparro M, Prado B, Cózar R, Méndez I, Banerjee D, Kaski JC, Cubero J, Cruz JM: The renoprotective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: The RENO Study. J Am Coll Cardiol 49: 1283-1288, 2007
32. Schmidt P, Pang D, Nykamp D, Knowlton G, Jia H: N-ace-tylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography. Ann Pharmacother 41: 46-50, 2007
33. Briguori C, Airoldi F, D'Andrea D, Bonizzoni E, Morici N, Focaccio A, Michev I, Montorfano M, Carlino M, Cosgrave J, Ricciardelli B, Colombo A: Renal Insufficiency following-Contrast Media Administration Trial (REMEDIAL): A randomized comparison of 3 preventive strategies. Circulation 115: 1211-1217, 2007
34. Richardson DE, Regino CA, Yao H, Johnson JV: Methionine oxidation by peroxymonocarbonate, a reactive oxygen species formed from CO2/ bicarbonate and hydrogen peroxide. Free Radic Biol Med 35: 1538-1550, 2003